Evidence map›Paper›PMID 35453184›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Fabrication and Evaluation of W/O Emulsion Loaded with

Barkat Ali Khan, Sumera Faiz, Muhammad Khalid Khan, Farid Menaa, Neli-Kinga Olah, Yosif Almoshari, Jawaher Abdullah Alamoudi, Saud Almawash

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Barkat Ali KhanDrug Delivery and Cosmetics Lab (DDCL), Faculty of Pharmacy, Gomal University, Dera Ismail Khan 29050, Pakistan.ORCID 0000-0003-4920-1770
Sumera FaizDrug Delivery and Cosmetics Lab (DDCL), Faculty of Pharmacy, Gomal University, Dera Ismail Khan 29050, Pakistan.
Muhammad Khalid KhanDrug Delivery and Cosmetics Lab (DDCL), Faculty of Pharmacy, Gomal University, Dera Ismail Khan 29050, Pakistan.ORCID 0000-0001-6079-6571
Farid MenaaDepartment of Nanomedicine and Dermatology, California Innovation Corporation, San Diego, CA 92113, USA.ORCID 0000-0002-0258-7322
Neli-Kinga OlahFaculty of Pharmacy, Vasile Goldiș Western University, 310045 Arad, Romania.ORCID 0000-0001-5204-6885
Yosif AlmoshariDepartment of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
Jawaher Abdullah AlamoudiDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh 11564, Saudi Arabia.
Saud AlmawashDepartment of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra 15273, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis, remains a serious health problem in many developing countries with thousands of new cases recorded annually. Novel therapies are required as existing treatment regimens are limited by their high cost, high toxicity, increased parasite resistance, patient's intolerance, and invasive means of long-duration administration. With several studies reporting the anti-leishmaniasis promise of medicinal plants, interest in plants and herbal drugs is attracting much attention worldwide. In this pilot study, we analysed extracts of

Indexed as

leishmaniasisLinum usitatissimumnutraceuticalwater-in-oil cream

Identifiers

PMID35453184
PMCPMC9031124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.